BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15448876)

  • 1. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
    Estato V; Araújo CV; Bousquet P; Tibiriçá E
    Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol selectively counteracts hypotension evoked by central I(1)-imidazoline but not alpha2-adrenergic receptor activation in spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):382-9. PubMed ID: 9733351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity.
    Schann S; Bruban V; Pompermayer K; Feldman J; Pfeiffer B; Renard P; Scalbert E; Bousquet P; Ehrhardt JD
    J Med Chem; 2001 May; 44(10):1588-93. PubMed ID: 11334568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ethanol on reductions in norepinephrine electrochemical signal in the rostral ventrolateral medulla and hypotension elicited by I1-receptor activation in spontaneously hypertensive rats.
    Mao L; Li G; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2003 Sep; 27(9):1471-80. PubMed ID: 14506409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central actions of agmatine in conscious spontaneously hypertensive rats.
    Briaud S; Zhang BL; Sannajust F
    Clin Exp Hypertens; 2005 Nov; 27(8):619-27. PubMed ID: 16303638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Godwin SJ; Tortelli CF; Parkin ML; Head GA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):195-204. PubMed ID: 9851569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of centrally acting sympathomodulatory drugs on myocardial ischemia induced by sympathetic overactivity in rabbits.
    Catelli M; Feldman J; Bousquet P; Tibirica E
    Braz J Med Biol Res; 2003 Jan; 36(1):85-95. PubMed ID: 12532231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I1 receptors, cardiovascular function, and metabolism.
    Bousquet P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of central I1 imidazoline receptor in ethanol counteraction of clonidine hypotension in spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):417-26. PubMed ID: 11486246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA; Burke SL; Chan CK
    J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional hemodynamic effects of rilmenidine and clonidine in the conscious spontaneously hypertensive rat.
    Smits JF; Struyker-Boudier HA
    Fundam Clin Pharmacol; 1991; 5(8):651-61. PubMed ID: 1783359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
    Szabo B; Fritz T; Wedzony K
    Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
    van Zwieten PA
    J Hypertens; 1997 Feb; 15(2):117-25. PubMed ID: 9469786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.